LAUSR

Revisiting mTOR inhibitors as anticancer agents.

Sign Up to like & get
recommendations!
0 Published in 2019 at "Drug discovery today"

DOI: 10.1016/j.drudis.2019.05.030

Abstract: The mammalian target of rapamycin (mTOR) is a highly conserved serine/threonine kinase that regulates a variety of cellular processes, influencing diverse pathological conditions including a variety of cancers. Accordingly, therapies that target mTOR as anticancer… read more here.

Keywords: mtor inhibitors; anticancer agents; mtor; revisiting mtor ... See more keywords